Literature DB >> 33971546

miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.

Chunxiu Hu1, Jianxiang Wu2, Li Wang1, Xuewu Liu1, Bin Da1, Yi Liu1, Lingyan Huang1, Qin Chen1, Yuefang Tong1, Zhongyu Jiang3.   

Abstract

OBJECTIVE: Lung adenocarcinoma (LUAD) is the most common type of lung cancer. This study aims to explore the mechanism by which CDCA8 regulates cell proliferation, invasion, and migration of LUAD, and to generate novel insights into targeted therapy of LUAD.
METHODS: Expression profiles of mature microRNAs (miRNAs) and mRNAs, along with clinical data of LUAD were downloaded from TCGA database for differential analysis and survival analysis to mine differentially expressed mRNAs. qRT-PCR was used to detect the expression of CDCA8 and miR-133b in LUAD cell lines, and western blot was used to detect protein expression. The effects of CDCA8 on the proliferation, migration, and invasion of LUAD cells were detected by CCK-8 assay, scratch healing assay, and Transwell assay. Bioinformatics predicted the target miRNA of CDCA8, and dual-luciferase reporter gene assay was used to verify the binding relationship between miR-133b and CDCA8.
RESULTS: Data from TCGA-LUAD showed that CDCA8 was significantly overexpressed in LUAD tissue, while its upstream miRNA (miR-133b) was significantly lowly expressed. The result of dual-luciferase test showed that miR-133b targeted CDCA8. The results of in vitro functional experiments showed that overexpression of CDCA8 could promote the proliferation, invasion, and migration of LUAD cells, and miR-133b could reverse this promotion by targeting CDCA8.
CONCLUSION: This study found that CDCA8 was a carcinogenic factor in LUAD cells and it was regulated by upstream miR-133b. miR-133b could inhibit proliferation, invasion, and migration of LUAD cells by targeting CDCA8.
Copyright © 2021 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CDCA8; Invasion; Migration; Proliferation; miR-133b

Mesh:

Substances:

Year:  2021        PMID: 33971546     DOI: 10.1016/j.prp.2021.153459

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer.

Authors:  Shun Wan; Yang He; Bin Zhang; Zhi Yang; Fang-Ming Du; Chun-Peng Zhang; Yu-Qiang Fu; Jun Mi
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

2.  An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.

Authors:  Zhiyun Xu; Shi Wang; Zhijian Ren; Xiang Gao; Lin Xu; Shuai Zhang; Binhui Ren
Journal:  World J Surg Oncol       Date:  2022-03-30       Impact factor: 2.754

3.  Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma.

Authors:  Shaohui Hou; Hongrui Xu; Shuzhong Liu; Bingjun Yang; Li Li; Hui Zhao; Chunyang Jiang
Journal:  Front Genet       Date:  2022-04-08       Impact factor: 4.772

4.  Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma.

Authors:  Zhaoshui Li; Zaiqi Ma; Hong Xue; Ruxin Shen; Kun Qin; Yu Zhang; Xin Zheng; Guodong Zhang
Journal:  Front Genet       Date:  2022-07-08       Impact factor: 4.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.